Advertisement
News
Subscribe to MDT Magazine News

SABCS 2010: Interview with Eric P. Winer, M.D.

December 11, 2010 12:31 pm | by AACR | Comments

SABCS 2010: Interview with Eric P. Winer, M.D., director of the Breast Oncology Center and Thompson senior investigator in breast cancer research at Dana-Farber Cancer Institute; professor of Medicine at Harvard Medical School Dr. Winer discusses breast cancer screening, the clinical...

TOPICS:

SABCS 2010: Interview with Robert E. Coleman, M.D.

December 11, 2010 10:31 am | by AACR | Comments

Dr. Coleman, chief investigator of the AZURE (Adjuvant Zoledronic Acid to Reduce Recurrence) trial, presents the rationale for studying the bisphosphonate zoledronic acid, and the final results of this study.

TOPICS:

SABCS 2010: Interview with Paul Workman, Ph.D., F.Med.Sci.

December 11, 2010 6:37 am | by AACR | Comments

Dr. Workman defines molecular chaperones and discusses their role in the cell, stress response pathways, heat shock proteins and the potential of this line of breast cancer research.

TOPICS:
Advertisement

SABCS 2010: Interview with Rowan T. Chlebowski, M.D. Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Chlebowski, lead investigator for the Women's Health Initiative, discusses the initiative's findings about the use of hormone therapy and its influence on cancer incidence and related cancer mortality, and the effects of bisphosphonates on breast cancer risk.

TOPICS:

SABCS 2010: Interview with Laura Esserman, M.D., M.B.A.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Esserman discusses her philosophy of holistic treatment and involving patients in the decision-making process, a cancer risk tracking system, and the I-Spy trials that match treatments to patients based on biomarkers.

TOPICS:

SABCS 2010: Interview with Klaus Pantel, M.D., Ph.D.

December 11, 2010 6:36 am | by AACR | Comments

Dr. Pantel discusses his findings about micrometastasis that contradict long-held beliefs about metastasis, and the implications of these discoveries for the treatment of breast cancer.

TOPICS:

SABCS 2010: Interview with Edith A. Perez, M.D.

December 11, 2010 6:35 am | by AACR | Comments

In this podcast, Dr. Perez discusses ALTTO (the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization study), the role of genetic markers in breast cancer treatment, the challenges of treating patients with triple-negative breast cancer, and the promise of personalized medicine.

TOPICS:

SABCS 2010: Interview with Charles M. Perou, Ph.D.

December 11, 2010 6:35 am | by AACR | Comments

Dr. Perou talks about genomic and genetic approaches to characterizing diverse breast cancers and their unique biologic features, using next-generation sequencing, and the implications of this science for clinical use.

TOPICS:
Advertisement

SABCS 2010: Interview with Rochelle Shoretz

December 11, 2010 6:35 am | by AACR | Comments

Ms. Shoretz talks about the mission of Sharsheret, how she came to establish this nonprofit organization, and her appointment to a federal advisory committee on breast cancer in young women.

TOPICS:

SABCS 2010: Interview with Sandi Stanford

December 11, 2010 6:34 am | by AACR | Comments

Ms. Stanford talks about the mission of the Alamo Breast Cancer Foundation and how advocates can take an active role in breast cancer research.

TOPICS:

SABCS 2010: HER2 Teleconference

December 11, 2010 5:34 am | by AACR | Comments

Neil Spector, M.D., professor of medicine at Duke University Medical Center, hosts this press conference.

TOPICS:

SABCS 2010: Circulating Tumor Cells and Metastasis Teleconference

December 11, 2010 5:34 am | by AACR | Comments

Minetta Liu, M.D., director of translational breast cancer research at Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, hosts this press conference.

TOPICS:

Govt won't contest ruling in steroids probe

December 10, 2010 5:45 pm | by PETE YOST - Associated Press - Associated Press | Comments

The government will not contest an appeals court ruling that investigators illegally seized a list of baseball players who allegedly tested positive for steroids, the Justice Department said Friday. That decision keeps intact a legal victory for scores of ballplayers snared in the doping...

Dental Products Panel to Consider Amalgam, Mercury Safety Issues

December 10, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

The FDA’s Dental Products Panel will be asked this week to consider what scientific methodology is needed to determine unsafe levels of dental amalgam and mercury, especially for children and other vulnerable patients.

TOPICS:

CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys(2)

December 10, 2010 2:32 pm | by U.S. Food & Drug Administration | Comments

As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading